Recalls from Viatris, Inc.

• Mylan Telmisartan and Amlodipine Tablets (opens in a new tab)
  Low risk, FDA, Oct 16, 2026, Wrong drug strength
• Viatris Xanax XR Extended-Release Tablets (opens in a new tab)
  Moderate risk, FDA, Apr 8, 2026, Drug dissolving problem

Data: Recall Canary (opens in a new tab)